Landmark International Study: CAR T-Cell Therapy Safe and Effective in Children and Young Adults with Leukemia
February 1, 2018
Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published on January 31 in the